 |
|
XDR TB in South Africa traced to lack of drug susceptibility testing
October 23, 2007In South Africa, the 2001 implementation of the World Health Organization's anti-tuberculosis program may have inadvertently helped to create a new strain of extensively drug-resistant tuberculosis (XDR TB). In a new study published in the December 1 issue of Clinical Infectious Diseases, currently available online, researchers tracked the developing drug resistance of one particular strain of Mycobacterium tuberculosis over 12 years. They found that at the time of the 2001 adoption of the DOT+ strategy for multi-drug resistant strains, the strain was already resistant to one or more of the drugs mandated by that strategy, thus allowing the strain to survive and develop resistance to additional drugs.
"The spread of a highly transmissible strain of drug-resistant tuberculosis has been facilitated by applying standard treatment regimens for susceptible and multi-drug resistant tuberculosis in the absence of drug resistance surveillance," said one of the authors, A. Willem Sturm, MD, of the University of KwaZulu-Natal's Nelson R. Mandela School of Medicine in South Africa. "Public health programs for the treatment and control of infectious diseases need to be supported by drug resistance surveillance programs."
Like all bacteria, M. tuberculosis can evolve and develop resistance to the drugs that have historically killed them. The strategy that has been used to limit the development of drug-resistant TB is to treat the patient with multiple drugs so that if one drug is ineffective, then the others will ensure the elimination of the bacteria.
Drug-resistant M. tuberculosis develops when tuberculosis patients cannot or do not comply with the medication regimen. A second line of drugs has been used to treat those infected with drug-resistant TB. This second-line medication regimen was adopted in South Africa in 2001 to treat drug-resistant TB.
Unfortunately, at least one strain of M. tuberculosis in South Africa had already developed resistance to one or more of these second-line drugs by the time they were introduced. Drug susceptibility tests would have warned doctors that the standard second-line regimen was unlikely to help the patient but was likely to lead to additional drug-resistance, but these tests were not performed or were not available. Indeed, the reduced efficacy of the regimen allowed the strain to survive and, over time, develop resistances to other drugs.
The authors recorded the development of resistance to seven drugs in just over a decade in one strain of M. tuberculosis. There are very few treatment options for patients infected with XDR TB. For the most part, patients are given drugs that had been used to treat tuberculosis but which were abandoned when today's first-line drugs became available. The older drugs were abandoned because they were less effective or more toxic.
The authors call for an increased use of drug resistance surveillance programs to help forestall the development of drug-resistance in M. tuberculosis.
Infectious Diseases Society of America
Drug-resistant M. tuberculosis develops when tuberculosis patients cannot or do not comply with the medication regimen. A second line of drugs has been used to treat those infected with drug-resistant TB. This second-line medication regimen was adopted in South Africa in 2001 to treat drug-resistant TB.
Unfortunately, at least one strain of M. tuberculosis in South Africa had already developed resistance to one or more of these second-line drugs by the time they were introduced. Drug susceptibility tests would have warned doctors that the standard second-line regimen was unlikely to help the patient but was likely to lead to additional drug-resistance, but these tests were not performed or were not available. Indeed, the reduced efficacy of the regimen allowed the strain to survive and, over time, develop resistances to other drugs.
The authors recorded the development of resistance to seven drugs in just over a decade in one strain of M. tuberculosis. There are very few treatment options for patients infected with XDR TB. For the most part, patients are given drugs that had been used to treat tuberculosis but which were abandoned when today's first-line drugs became available. The older drugs were abandoned because they were less effective or more toxic.
The authors call for an increased use of drug resistance surveillance programs to help forestall the development of drug-resistance in M. tuberculosis.
Infectious Diseases Society of America
Tuberculosis News and Current Tuberculosis Events RSSNew method to overcome multiple drug resistant diseases developed by Stanford researchers
Many drugs once considered Charles Atlases of the pharmaceutical realm have been reduced to the therapeutic equivalent of 97-pound weaklings as the diseases they once dispatched with ease have developed resistance to them.
India continues to progress in AIDS vaccine development efforts
A second Phase I AIDS vaccine clinical trial in India was successfully completed, the Indian Council of Medical Research, the National AIDS Control Organization and the International AIDS Vaccine Initiative announced. The results of the trial of an MVA-based AIDS vaccine candidate (TBC-M4), which was conducted in Chennai, indicated that the vaccine candidate had acceptable levels of safety and was well tolerated.
Extensively drug-resistant tuberculosis found in California
In the first statewide study of extensively drug-resistant tuberculosis (XDR TB) in the United States, California officials have identified 18 cases of the dangerous and difficult-to-treat disease between 1993 and 2006, and 77 cases that were one step away from XDR TB. The study appears in the August 15 issue of Clinical Infectious Diseases, now available online.
Comprehensive treatment of extensively drug-resistant TB works, study finds
The death sentence that too often accompanies a diagnosis of extensively drug-resistant tuberculosis (XDR-TB) can be commuted if an individualized outpatient therapy program is followed - even in countries with limited resources and a heavy burden of TB.
Treatment outcomes highlight dangers of extensively drug-resistant tuberculosis
In a retrospective study of 174 tuberculosis patients treated at National Jewish Health (formerly National Jewish Medical and Research Center), patients with extensively-drug-resistant tuberculosis (XDR-TB) were almost eight times as likely to die as patients with multi-drug resistant tuberculosis (MDR-TB).
Ben-Gurion University of the Negev initiates project to eliminate intestinal worms in Ethiopia
A professor at The Faculty of Health Sciences at Ben-Gurion University of the Negev (BGU) is beginning an intensive program in Ethiopia this August to eradicate intestinal worms which affect as much as 50 percent of the population in Africa.
Certain HIV treatment less effective when used with anti-TB therapy
Patients receiving rifampicin-based anti-tuberculosis therapy are more likely to experience virological failure when starting nevirapine-based antiretroviral therapy, an HIV treatment that is widely used in developing countries because of lower cost, than when starting efavirenz-based antiretroviral therapy.
Study helps identify which populations of foreign-born persons living in US at higher risk of TB
The relative yield of finding and treating latent tuberculosis is particularly high among higher-risk groups of foreign-born persons living in the U.S., such as individuals from most countries of sub-Saharan Africa and Southeast Asia.
Tuberculosis presents major challenges to HIV treatment in developing countries
Human immunodeficiency virus (HIV) care and treatment programs in resource-limited settings must aggressively address tuberculosis (TB) and the emerging multidrug-resistant TB epidemic to save patient lives and to curb the global TB burden, a major cause of death for persons with HIV.
Bovine tuberculosis in wildlife threatens endangered lynx and cattle health
In an epidemiological survey of Spain's Doñana National Park, the findings of which are published on July 23 in the journal PLoS ONE, Christian Gortázar and colleagues studied the prevalence of bovine tuberculosis (bovine TB) infection among populations of wild boar, red deer and fallow deer in the national park, which is located in southern Spain.
More Tuberculosis News Articles
 | Illness as Metaphor and AIDS and Its Metaphors by Susan Sontag In 1978 Susan Sontag wrote Illness as Metaphor, a classic work described by Newsweek as "one of the most liberating books of its time." A cancer patient herself when she was writing the book, Sontag shows how the metaphors and myths surrounding certain illnesses, especially cancer, add greatly to the suffering of patients and often inhibit them from seeking proper treatment. By demystifying the... |
 | The Air We Breathe: A Novel by Andrea Barrett The exquisite, much-anticipated new novel by the author of Ship Fever, winner of the National Book Award.In fall 1916, Americans debate whether to enter the European war. "Preparedness parades" march and headlines report German spies. But in an isolated community in the Adirondacks, the danger is barely felt. At Tamarack Lake the focus is on the sick. Wealthy tubercular patients live in private... |
 | Identification Problems in the Social Sciences by Charles F. Manski This book provides a language and a set of tools for finding bounds on the predictions that social and behavioral scientists can logically make from nonexperimental and experimental data. The economist Charles Manski draws on examples from criminology, demography, epidemiology, social psychology, and sociology as well as economics to illustrate this language and to demonstrate the broad... |
 | Basic Infection Control for Healthcare Providers by Michael Kennamer Basic Infection Control for Health Care Providers, Second Edition, is a clear and concise guide to preventing occupational exposure hazards and communicable and infectious diseases. This book includes coverage on how to safely protect oneself from infectious agents and what do in case of infectious exposure. Discussions of the disease process and legal issues surrounding exposure and infectious... |
 | New Topics in Tuberculosis Research |
 | Behold the Many: A Novel by Lois-Ann Yamanaka In 1913, stricken by tuberculosis, young Anah, Aki, and Leah are sent away from their family for treatment at St. Joseph's, an orphanage in Hawai'i's Kalihi Valley. Of the three, two will die there, and only Anah, the eldest, will survive. But the ghosts of the dead sisters will haunt Anah as she prepares to begin married life away from the orphanage. Desperate for the love of their sister, but... |
 | The Night Journal by Elizabeth Crook A brilliantly imagined, lavish, and transporting novel of a young woman’s search for the truth about her family’s mythic past Meg Mabry has spent her life with her back turned to her legendary family legacy. In the 1890s her great-grandmother Hannah Bass composed starkly revealing diaries of her life on the southwestern frontier, first as a Harvey Girl at the glamorous Montezuma Resort in New... |
 | The Bioarchaeology of Tuberculosis: A Global View on a Reemerging Disease by CHARLOTTE ROBERTS, JANE BUIKSTRA Though apparently in decline during the first half of the 20th century, tuberculosis has reawakened in both developed and developing countries, particularly among susceptible populations with immunodeficiency disorders.... |
 | The White Plague: Tuberculosis, Man, and Society by Rene J. Dubos |
 | The Nigger of the "Narcissus" (Dover Thrift Editions) by Joseph Conrad A dying sailor boards the Narcissus and acts as a memento mori upon his shipmates, eliciting pity and selfless compassion as well as fear, resentment, and a profound hatred. The powerful narrative technique captures every nuance of atmospheric tension for a compelling study of men's characters under conditions of extreme danger and... |
| © 2008 BrightSurf.com |